366. Ozempic, Mounjaro, Trulicity...Is It Worth the Risk?

GLP-1's...Is diving into these worth the risks?" Glucagon-like Peptide-1's is a crucial topic, especially for those exploring options for managing type 2 diabetes or looking for weight loss solutions. GLP-1's initially emerged as a groundbreaking treatment for type 2 diabetes, with Trulicity being one of the first on the market. These medications work by stimulating insulin release from the pancreas, effectively reducing high blood glucose levels. This is vital for those with type 2 diabetes, as consistently high glucose can lead to severe complications like neuropathy, blindness, and even cardiovascular diseases. Ozempic, later introduced, was FDA-approved not just for diabetes management but also for reducing the risk of major cardiovascular events in people with pre-existing heart conditions and type 2 diabetes. Similarly, Mounjaro follows the same mechanism, mimicking the GLP-1 hormone to regulate blood glucose levels. However, it's not all smooth sailing. These medications can significantly impact digestion, often leading to a slowdown in gastric emptying. This episode doesn't shy away from discussing the potential side effects, including heartburn, nausea, a sense of fullness that affects appetite, and sometimes even severe gastrointestinal symptoms. Join me as I navigate through these complexities, weigh the benefits against the risks, and provide insights that could help you make informed decisions about using GLP-1's. Whether you're considering them for diabetes management or as part of your weight loss journey, this episode is an invaluable resource. Tune in to uncover the truths and myths about these widely discussed medications. Shop ALL of Dr.